These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30652344)

  • 1. Actigraphy-measured nocturnal wrist movements and assessment of sleep quality in patients with bullous pemphigoid: a pilot case-control study.
    Kalinska-Bienias A; Piotrowski T; Kowalczyk E; Lesniewska A; Kaminska M; Jagielski P; Kowalewski C; Wozniak K
    Clin Exp Dermatol; 2019 Oct; 44(7):759-765. PubMed ID: 30652344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.
    Ben Mordehai Y; Faibish H; Astman N; Greenberger S; Barzilai A; Baum S
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):161-165. PubMed ID: 31423677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients.
    Lévy-Sitbon C; Barbe C; Plee J; Goeldel AL; Antonicelli F; Reguiaï Z; Jolly D; Grange F; Bernard P
    Dermatology; 2014; 229(2):116-22. PubMed ID: 25011586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
    Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
    Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
    Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
    Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary habits in Japanese patients with bullous pemphigoid: low intake of retinol.
    Uozumi T; Serizawa N; Hagino T; Morita T; Mizuno M; Ichiyama S; Hoashi T; Saeki H; Matsuda H; Nakagawa K; Mitsui H; Kanda N
    Eur J Dermatol; 2023 Aug; 33(4):394-403. PubMed ID: 37823490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?
    Wijayanti A; Zhao CY; Boettiger D; Chiang YZ; Ishii N; Hashimoto T; Murrell DF
    Acta Derm Venereol; 2017 Jan; 97(1):24-31. PubMed ID: 27244117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
    Hon KL; Lam MC; Wong KY; Leung TF; Ng PC
    Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.
    Clapé A; Muller C; Gatouillat G; Le Jan S; Barbe C; Pham BN; Antonicelli F; Bernard P
    Front Immunol; 2018; 9():479. PubMed ID: 29662486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
    Masmoudi W; Vaillant M; Vassileva S; Patsatsi A; Quereux G; Moltrasio C; Abasq C; Prost-Squarcioni C; Kottler D; Kiritsi D; Litrowski N; Plantin P; Friedrichsen L; Zebrowska A; Duvert-Lehembre S; Hofmann S; Ferranti V; Jouen F; Joly P; Hebert V;
    Br J Dermatol; 2021 Jun; 184(6):1106-1112. PubMed ID: 33067805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of pruritus in patients with bullous pemphigoid: a preliminary questionnaire-based study.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Lesniewska A; Komorowska A; Kowalewski C; Wozniak K
    Postepy Dermatol Alergol; 2020 Dec; 37(6):938-942. PubMed ID: 33603613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Disease Outcome Measures in Bullous Pemphigoid on Standard-Of-Care Therapies.
    Cole EF; DeGrazia T; Sun Y; Liu Y; Feldman RJ
    JID Innov; 2021 Dec; 1(4):100050. PubMed ID: 34909747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid.
    Gore Karaali M; Koku Aksu AE; Cin M; Leblebici C; Kara Polat A; Gurel MS
    Australas J Dermatol; 2021 May; 62(2):e236-e241. PubMed ID: 33748980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.
    Sadik CD; Rashid H; Hammers CM; Diercks GFH; Weidinger A; Beissert S; Schauer F; Fettiplace J; Thaçi D; Ngai Y; Nunn MA; Zillikens D; Horváth B
    JAMA Dermatol; 2022 Jun; 158(6):641-649. PubMed ID: 35507334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of D-dimer and fibrin degradation products correlate with bullous pemphigoid severity: a cross-sectional study.
    Wang S; Lu M; Zhao Z; Peng X; Li L; Cheng C; Fang M; Xia Y; Liu Y
    Sci Rep; 2021 Sep; 11(1):17746. PubMed ID: 34493780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Bullous Pemphigoid: A Single-Center Retrospective Study.
    Moar A; Azzolini A; Tessari G; Schena D; Girolomoni G
    Dermatology; 2021; 237(6):1039-1045. PubMed ID: 33979792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment.
    Ujiie I; Iwata H; Yoshimoto N; Izumi K; Shimizu H; Ujiie H
    J Dermatol; 2021 Apr; 48(4):502-510. PubMed ID: 33600037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional assessment of sleep and fatigue in middle-aged Japanese women with primary Sjogren syndrome or rheumatoid arthritis using self-reports and wrist actigraphy.
    Miyauchi K; Fujimoto K; Abe T; Takei M; Ogawa K
    Medicine (Baltimore); 2021 Sep; 100(37):e27233. PubMed ID: 34664865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.